title: Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
authors.affiliation: Department of Hematology and Oncology, Klinikum Steglitz, Free University of Berlin, Fed. Rep. of Germany.
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: J
authors.initials: J
authors.lastname: Harbott
authors.forename: C R
authors.initials: CR
authors.lastname: Bartram
authors.forename: B
authors.initials: B
authors.lastname: Komischke
authors.forename: C
authors.initials: C
authors.lastname: Sperling
authors.forename: J V
authors.initials: JV
authors.lastname: Teichmann
authors.forename: H
authors.initials: H
authors.lastname: Seibt-Jung
authors.forename: M
authors.initials: M
authors.lastname: Notter
authors.forename: E
authors.initials: E
authors.lastname: Odenwald
authors.forename: A
authors.initials: A
authors.lastname: Nehmer
mesh_terms: D000293:Adolescent; D015703:Antigens, CD / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D015994:Incidence; D007223:Infant; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000188:drug therapy / Q000235:genetics / Q000276:immunology* / Q000401:mortality; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D015703:Antigens, CD